Anterior segment optical coherence tomography (AS-OCT) for the visualization and quantification of dose-dependent ocular toxicity

Jonathan Lin; Jonathan Luisi; Nishad Karediya; Edward R. Kraft; Ardalan Sharifi; Mary E. Schmitz-Brown; Kevin H. Merkley; Praveena Gupta; Massoud Motamedi

doi:10.1117/12.2608329

4 March 2022 Anterior segment optical coherence tomography (AS-OCT) for the visualization and quantification of dose-dependent ocular toxicity

Jonathan Lin, Jonathan Luisi, Nishad Karediya, Edward R. Kraft, Ardalan Sharifi, Mary E. Schmitz-Brown, Kevin H. Merkley, Praveena Gupta, Massoud Motamedi

Author Affiliations +

Proceedings Volume 11941, Ophthalmic Technologies XXXII; 119410I (2022) https://doi.org/10.1117/12.2608329
Event: SPIE BiOS, 2022, San Francisco, California, United States

Conference Poster

Abstract

Optical coherence tomography (OCT) is a well-established, non-invasive, high-resolution retinal imaging modality that is gaining widespread popularity in the clinic to assess pathological changes in the anterior segment, such as corneal edema, fibrosis, and neovascularization. We examined the potential of anterior segment (AS-OCT) as a quantitative and qualitative tool for grading ocular injury following chemical exposure. Current clinical ocular toxicity assessment primarily evaluates ocular surface changes, neglecting any deeper damage, and is largely incapable of gauging the depth of damage, a key prognostic determinant. In this work, we demonstrate the capability of AS-OCT to visualize ocular changes, such as Descemet’s membrane detachment, corneal swelling, epithelial keratinization, and iris damage. Furthermore, we show consistent differences in the progression of corneal damage following chemical exposure at mild, moderate, and severe dose levels and attempt to quantify some of these changes, such as corneal thickness and neovascularization. In conclusion, AS-OCT combined with OCT angiography (OCTA) is a powerful non-invasive imaging tool for monitoring changes in the eye and provides an improved understanding of the concentration-dependent progression of chemical injury. As such, AS-OCT can guide the clinical management of ocular chemical exposures, as well as advance eye irritation safety testing.

Citation Download Citation

Jonathan Lin, Jonathan Luisi, Nishad Karediya, Edward R. Kraft, Ardalan Sharifi, Mary E. Schmitz-Brown, Kevin H. Merkley, Praveena Gupta, and Massoud Motamedi "Anterior segment optical coherence tomography (AS-OCT) for the visualization and quantification of dose-dependent ocular toxicity", Proc. SPIE 11941, Ophthalmic Technologies XXXII, 119410I (4 March 2022); https://doi.org/10.1117/12.2608329

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available